男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Ovarian cancer forum held in Beijing

By Zhou Wenting in Shanghai | chinadaily.com.cn | Updated: 2023-05-08 16:07
Share
Share - WeChat
Experts discuss long-term survival of ovarian cancer patients at a forum on Monday, the 11th World Ovarian Cancer Day. [Photo provided to chinadaily.com.cn]

Helping ovarian cancer patients attain high-quality, long-term survival is now the key focus of medical treatments of the disease, said experts at a forum held in Beijing on Monday, which marked the 11th World Ovarian Cancer Day.

During the forum, doctors shared their latest views and medical practices while patients and their families shared their personal experiences.

The event was jointly hosted by the Beijing Bethune Charitable Foundation and the Health App of People's Daily, and supported by the foundation and Zailab, a domestic innovative biopharmaceutical company.

Di Wen, president of the obstetricians and gynecologists branch of the Chinese Medical Doctor Association and director of the obstetrics and gynecology department of Shanghai Renji Hospital, said that ovarian cancer has a hidden onset and there are no typical symptoms in early stages.

However, experts have reached a consensus that the treatment of ovarian cancer has entered an era of chronic disease management, and doctors and patients should consider recurrent ovarian cancer as a chronic disease.

Prolonging the interval between the completion of chemotherapy and a recurrence or disease progression is currently the main approach to improving the prognosis of patients with recurrent ovarian cancer, said experts.

"The use of PARP inhibitor as maintenance treatment is aimed at prolonging the interval and enhancing the effectiveness of relapse treatment, which would improve the survival of ovarian cancer patients. In this way, it will be no longer difficult to achieve a five-year survival for many patients," said Wu Ming, a chief physician at the gynecological oncology center of the Peking Union Medical College Hospital.

With the application of personalized and precise medical treatment methods, including gene testing, the treatment level of ovarian cancer in China is now on par with that in the West, said Zhang Shiqian, a chief physician at the obstetrics and gynecology department of Qilu Hospital of Shandong University.

"The five-year survival rate among patients has improved these years, and so has the recurrence rate," said Zhang, who is also chairman of the ovarian cancer committee of integrated traditional Chinese and western medicine affiliated with the China Anti-Cancer Association.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 龙泉市| 商城县| 桐梓县| 阿巴嘎旗| 濉溪县| 明光市| 灵宝市| 沧源| 老河口市| 黄平县| 封丘县| 治县。| 凤台县| 株洲市| 如东县| 岱山县| 东丰县| 舒兰市| 西乌| 鱼台县| 西宁市| 昌平区| 于都县| 洪雅县| 类乌齐县| 文山县| 谢通门县| 鄂州市| 高密市| 蒙阴县| 甘谷县| 新乡县| 苍南县| 湘潭县| 门源| 农安县| 安多县| 武汉市| 女性| 肃南| 象山县|